A A Sasahara, G V Sharma, A F Parisi. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Aspirin/administration & dosageAspirin/therapeutic useClothingDextrans/administration & dosageDextrans/therapeutic useElectric Stimulation TherapyFibrinolytic AgentsHeparin/administration & dosageHeparin/therapeutic useHip Joint/surgeryHumansHydroxychloroquine/administration & dosageHydroxychloroquine/therapeutic useJoint ProsthesisLeg/blood supplyNeurosurgeryPlethysmography, ImpedancePostoperative CarePostoperative Complications/diagnosisPostoperative Complications/prevention & controlPressurePulmonary Embolism/diagnosisPulmonary Embolism/prevention & controlThrombophlebitis/diagnosisThrombophlebitis/prevention & control
Substances： See more » DextransFibrinolytic AgentsHydroxychloroquineHeparinAspirin
Year: 1979 PMID： 375711 DOI： 10.1016/0002-9149(79)90156-5
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778